High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma
Purpose: To report on the use of intravitreal high-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous retinoblastoma, the toxicity of these injections, and the use of a 180-μG injection of intravitreal topotecan in humans. Observations: High-dose (90 and 180 μG) intravitreal topote...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2025-12-01
|
| Reeks: | American Journal of Ophthalmology Case Reports |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2451993625001902 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|